{
    "name": "nitric oxide gas",
    "comment": "Rx",
    "other_names": [
        "INOmax",
        "Genosyl"
    ],
    "classes": [
        "Pulmonary",
        "Other"
    ],
    "source": "https://reference.medscape.com/drug/inomax-genosyl-nitric-oxide-gas-343457",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: not known if excreted in breast milk"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: not known if excreted in breast milk"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity",
                "Neonates dependent on right-to-left shunting of blood"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Methemoglobinemia and NO2 levels are dose dependent; the most common adverse reaction is hypotension",
                "Closely monitor PaO2 and methemoglobin levels; measure methemoglobin levels within 4-8 hr after initiation of treatment and then periodically throughout treatment",
                "Monitor NO2 levels continuously with a suitable nitric oxide delivery system",
                "If methemoglobin levels are elevated and do not resolve with decreased dose or discontinuation, additional therapy may be warranted (eg, IV vitamin C, IV methylene blue, blood transfusion); hypoxemia from methemoglobinemia may occur",
                "Wean gradually to avoid rebound pulmonary hypertension syndrome; symptoms include worsening oxygenation, increased pulmonary artery pressure (PAP), systemic hypotension, and decreased cardiac output; reinstate nitric oxide immediately",
                "Nitrogen dioxide (NO2) forms in gas mixtures containing NO and O2 and may cause airway inflammation and damage to lung tissues; if NO2 exceeds 0.5 ppm, decrease the dose of nitric oxide",
                "If there is unexpected change in NO2 concentration, or if NO2 concentration reaches 3 ppm when measured in breathing circuit, assess delivery system; may need to adjust dose as appropriate",
                "Patients with left ventricular dysfunction may experience pulmonary edema when treated with nitric oxide, increased pulmonary capillary wedge pressure, worsening of left ventricular dysfunction, systemic hypotension, bradycardia, and cardiac arrest"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Hypotension",
            "percent": "13"
        },
        {
            "name": "Withdrawal",
            "percent": "12"
        },
        {
            "name": "Atelectasis",
            "percent": "9"
        },
        {
            "name": "Hematuria",
            "percent": "8"
        },
        {
            "name": "Hyperglycemia",
            "percent": "8"
        },
        {
            "name": "Sepsis",
            "percent": "7"
        },
        {
            "name": "Infection",
            "percent": "6"
        },
        {
            "name": "Cellulitis",
            "percent": "5"
        },
        {
            "name": "Stridor",
            "percent": "5"
        },
        {
            "name": "Intracranial hemorrhage",
            "percent": null
        },
        {
            "name": "due to platelet aggregation inhibition",
            "percent": null
        },
        {
            "name": "Seizure",
            "percent": null
        },
        {
            "name": "Gastrointestinal hemorrhage due to platelet aggregation inhibition",
            "percent": null
        },
        {
            "name": "Methemoglobinemia",
            "percent": null
        },
        {
            "name": "Hematuria due to platelet aggregation inhibition",
            "percent": null
        },
        {
            "name": "Acute lung injury",
            "percent": null
        },
        {
            "name": "atelectasis",
            "percent": null
        },
        {
            "name": "hypoxemia",
            "percent": null
        },
        {
            "name": "pulmonary edema",
            "percent": null
        },
        {
            "name": "pulmonary hemorrhage",
            "percent": null
        },
        {
            "name": "pulmonary toxicity due to nitrogen dioxide formation",
            "percent": null
        },
        {
            "name": "Accidental exposure to nitric oxide for inhalation in hospital staff has been associated with chest discomfort",
            "percent": null
        },
        {
            "name": "dizziness",
            "percent": null
        },
        {
            "name": "dry throat",
            "percent": null
        },
        {
            "name": "dyspnea",
            "percent": null
        },
        {
            "name": "and headache",
            "percent": null
        }
    ]
}